Lv1
20 积分 2026-05-09 加入
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD
1个月前
已完结
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
1个月前
已完结
VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C
1个月前
已完结
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
1个月前
已完结
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial
1个月前
已完结
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
1个月前
已完结
VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C
1个月前
已关闭
Meta-Analysis of Inclisiran for the Treatment of Hypercholesterolemia
1个月前
已完结
Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
